iRhythm Holdings, Inc (NASDAQ:IRTC) is among the best medical AI stocks to buy now. At the American College of Cardiology 2026 Annual Scientific Sessions on March 30, iRhythm shared analysis results that cast its cardiac monitoring service in a favorable light. The studies analyzed data from thousands of patients using iRhythm’s Zio cardiac monitoring device. The company provides cardiac monitoring devices and software that use artificial intelligence.
Jirsak/Shutterstock.com
In one study, the analysis found that there were clinically actionable arrhythmias in 48% of patients with chronic kidney disease and 47% of patients with both chronic kidney disease and diabetes. That compared with 39% of patients with diabetes only and 35% of patients with none of these conditions. This study reviewed data from 657,147 people who received 14 days of continuous monitoring.
In a second study, the analysis showed that patients with severe obesity were 2.8 times more likely to be found with atrial fibrillation detection compared to normal or underweight patients.
On the day iRhythm shared these study results, it announced the launch of an education platform targeting healthcare professionals in cardiac monitoring. The company calls it the iRhythm Academy. iRhythm is trying to educate doctors about its cardiac monitoring products at a time when it’s targeting an expanding market. The global market for smart wearable ECG monitors, such as iRhythm’s Zio, is on course to grow from $1.98 billion in 2024 to $3.54 billion by 2030, according to Grand View Research.
iRhythm’s revenue rose 26.2% to $747.1 million in 2025. This growth was due to increased demand for Zio services. The Q4 2025 revenue of $208.9 million increased 27.1% YoY and surpassed the consensus projection of $201.8 million.
iRhythm Holdings, Inc (NASDAQ:IRTC) is a digital healthcare company based in California. It offers cardiac monitoring services to help detect and prevent disease. Its portfolio includes monitoring devices and accompanying software solutions. iRhythm’s Zio cardiac monitor device is a lightweight adhesive patch worn on the chest.
While we acknowledge the risk and potential of IRTC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than IRTC and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: David Abrams’ Hedge Fund Is Betting On These 8 Stocks and 10 Best Energy Storage Stocks to Buy According to Hedge Funds.
Disclosure: None. Follow Insider Monkey on Google News.
Hedge Fund Resource Center